{"nct_id":"NCT00126451","title":"A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Relapsed or Refractory Breast, Colorectal and Non-Small Cell Lung Cancer (0683-011)(TERMINATED)","status":"TERMINATED","status_verified_date":"2017-04","start_date":"2004-12-01","start_date_type":"ACTUAL","primary_completion_date":"2005-10-11","primary_completion_date_type":"ACTUAL","completion_date":"2005-10-11","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["MRK"]}